MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.soard.2024.05.016

Медицинская библиотека · Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2024

Bariatric surgery and COVID-19 outcomes: results from the PaTH to Health: Diabetes study.

Soleymani Taraneh, Lehman Erik B, Kong Lan, Poger Jennifer M, Yeh Hsin-Chieh, Kraschnewski Jennifer L

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Obesity and type 2 diabetes mellitus (T2DM) are risk factors for severe COVID-19 infection. Bariatric surgery (BSG) is an effective treatment of obesity through weight loss and may reduce COVID-19 severity.

OBJECTIVES

We examined the effect of BSG on COVID-19 outcomes in patients with or at risk of T2DM.

SETTING

Electronic health record data from the PaTH Clinical Data Research Network, a partnership of 5 health systems reviewed from March 1, 2020, to December 31, 2020.

METHODS

Ambulatory and in-hospital patient encounters with COVID-19 diagnosis and obesity were identified. We constructed 2 patient groups: BSG and non-BSG (NBSG). The BSG group included patients with at least 1 encounter for the BSG procedure code and/or 1 BSG diagnosis code; the NBSG group included patients with no procedure or diagnosis code for BSG with body mass index (BMI) ≥40 or BMI ≥35 and at least 2 obesity-related co-morbidities. We matched 1 patient in the BSG group to 2 patients in the NBSG group based on age, gender (sex defined at birth), race and ethnicity, group (T2DM and at risk of T2DM), and site. The primary outcome was 30-day outcomes of COVID-19 severity.

RESULTS

After matching, we found that patients with BSG had lower odds of respiratory failure (41%) and ventilation/intensive care unit (ICU) admission/death (52%). Patients in the BSG group had lower odds of hospitalization, pneumonia, respiratory failure, and the most severe COVID-19 outcomes combined (ventilation/ICU admission/death). T2DM was identified as a risk factor for COVID-19 severity in the BSG group.

CONCLUSIONS

This retrospective, matched-cohort analysis found BSG to have a protective effect against severe COVID-19 outcomes.

Для цитирования: Soleymani Taraneh, Lehman Erik B, Kong Lan, Poger Jennifer M, Yeh Hsin-Chieh, Kraschnewski Jennifer L. Bariatric surgery and COVID-19 outcomes: results from the PaTH to Health: Diabetes study.. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2024. DOI: 10.1016/j.soard.2024.05.016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.